Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp16401_8k.htm |
Exhibit
99.01
|
Press Release
www.shire.com
|
 |
Full
Year 2009 results date notification – 19 February 2010
February 4, 2010 – Shire plc
(LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will
announce full year 2009 earnings on Friday 19 February 2010.
|
Results press
release will be issued at:
|
12:00 GMT /
07:00 EST
|
|
Investor
conference call time:
|
14:00 GMT /
09:00 EST
|
Angus Russell,
Chief Executive Officer, Graham Hetherington, Chief Financial Officer, Mike
Cola, President, Specialty Pharmaceuticals and Sylvie Grégoire, President, Human
Genetic Therapies will host the investor and analyst conference call at 14:00
GMT/9:00 EST.
The details of the
conference call are as follows:
|
UK dial
in:
|
0844 800 3850
or 01296 311 600
|
|
US dial
in:
|
1 866 8048688
or 1 718 3541175
|
|
International
dial in:
|
+44 (0) 1296
311 600
|
|
Password/Conf
ID:
|
587
261#
|
|
Live
Webcast:
|
http://www.shire.com/shireplc/en/investors
|
Replay:
A
replay of the conference call will be available by phone for two weeks and on
our website for 12 months. For further information; please visit our
Investor Relations’ website.
http://www.shire.com/shireplc/en/investors
For
further information please contact:
|
Investor
Relations
|
Souheil
Salah
|
+44 1256 894
160
|
|
Ricki
Greenwood
|
+1 (484)
595-8517
|
Notes
to editors
SHIRE
PLC
Shire’s strategic
goal is to become the leading specialty biopharmaceutical company that focuses
on meeting the needs of the specialist physician. Shire focuses its
business on attention deficit hyperactivity disorder (ADHD), human genetic
therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in
other therapeutic areas to the extent they arise through
acquisitions. Shire’s in-licensing, merger and acquisition efforts
are focused on products in specialist markets with strong intellectual property
protection and global rights. Shire believes that a carefully
selected and balanced portfolio of products with strategically aligned and
relatively small-scale sales forces will deliver strong results.
For further
information on Shire, please visit the Company’s website: www.shire.com.
Registered in Jersey, No. 99854,
22 Grenville
Street, St Helier,
Jersey JE4 8PX